LISATA THERAPEUTICS, INC. — Revenue by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8b5a8a96-9a41-428c-a61a-24d24927f852/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $170.0k | 2025-01-01 – 2025-12-31 | evidence 0000320017-26-000023 |
| FY 2024 | $1.0M | 2024-01-01 – 2024-12-31 | evidence 0000320017-25-000011 |
| FY 2023 | $0 | 2023-01-01 – 2023-12-31 | evidence 0000320017-24-000007 |
| FY 2022 | $0 | 2022-01-01 – 2022-12-31 | evidence 0000320017-24-000007 |
| FY 2016 | $35.3M | 2016-01-01 – 2016-12-31 | evidence 0000320017-17-000008 |
| FY 2015 | $22.5M | 2015-01-01 – 2015-12-31 | evidence 0000320017-16-000098 |
| FY 2014 | $17.9M | 2014-01-01 – 2014-12-31 | evidence 0000320017-15-000013 |
| FY 2013 | $14.7M | 2013-01-01 – 2013-12-31 | evidence 0000320017-14-000007 |
| FY 2012 | $14.3M | 2012-01-01 – 2012-12-31 | evidence 0000320017-13-000009 |
| FY 2011 | $10.1M | 2011-01-01 – 2011-12-31 | evidence 0001445305-12-002656 |
| FY 2010 | $181.1k | 2010-01-01 – 2010-12-31 | evidence 0001445305-12-002656 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
LISATA THERAPEUTICS, INC. — all facts · Net Income · Operating Income